Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2 from the Record History.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedNew revision added: v3.4.2, replacing v3.4.1 in the history. No substantive page content changes are evident.SummaryDifference0.0%

- Check37 days agoChange DetectedAn additional revision entry v3.4.1 is added and the previous v3.4.0 entry is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page history shows Revision: v3.3.4 in place of the previous v3.3.3. There are no visible changes to the study details or other user-facing content.SummaryDifference0.0%

- Check80 days agoChange DetectedA new Revision: v3.3.3 was added; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check109 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.2 with no changes to study data or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.